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Drugs of abuse increase the activity of dopaminergic neurons of the ventral tegmental
area (VTA), and output from the VTA is critical for both natural and drug-induced reward
and reinforcement. Ethanol and the abused inhalant toluene both enhance VTA neuronal
firing, but the mechanisms of this effect is not fully known. In this study, we used
extracellular recordings to compare the actions of toluene and ethanol on DA VTA
neurons. Both ethanol and toluene increased the firing rate of DA neurons, although
toluene was ∼100 times more potent than ethanol. The mixed ion channel blocker
quinine (100µM) blocked the increases in firing produced by ethanol and toluene,
indicating some similarity in mechanisms of excitation. A mixture of antagonists of
GABA and cholinergic receptors did not prevent toluene-induced or ethanol-induced
excitation, and toluene-induced excitation was not altered by co-administration of
ethanol, suggesting independent mechanisms of excitation for ethanol and toluene.
Concurrent blockade of NMDA, AMPA, andmetabotropic glutamate receptors enhanced
the excitatory effect of toluene while having no significant effect on ethanol excitation.
Nicotine increased firing of DA VTA neurons, and this was blocked by the nicotinic
antagonist mecamylamine (1µM). Mecamylamine did not alter ethanol or toluene
excitation of firing but the muscarinic antagonist atropine (5µM) or a combination of
GABA antagonists (bicuculline and CGP35348, 10µM each) reduced toluene-induced
excitation without affecting ethanol excitation. The Ih current blocker ZD7288 abolished
the excitatory effect of toluene but unlike the block of ethanol excitation, the effect of
ZD7288 was not reversed by the GIRK channel blocker barium, but was reversed by
GABA antagonists. These results demonstrate that the excitatory effects of ethanol and
toluene have some similarity, such as block by quinine and ZD7288, but also indicate
that there are important differences between these two drugs in their modulation by
glutamatergic, cholinergic, and GABAergic receptors. These findings provide important
information regarding the actions of abused inhalants on central reward pathways, and
suggest that regulation of the activation of central dopamine pathways by ethanol and
toluene partially overlap.
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INTRODUCTION
Dopaminergic neurons of the ventral tegmental area (DA
VTA) play important roles in mediation of the rewarding and
reinforcing effect of drugs of abuse (Wise, 1996; Koob and
Volkow, 2010). All known drugs of abuse increase the firing rate
of these neurons, and activation of the VTA and the subsequent
release of dopamine in the terminal regions of the nucleus
accumbens (NAc; Di Chiara and Imperato, 1988; Di Chiara et al.,
2004) are well-correlated with the reinforcing actions of drugs
of abuse. While recent studies have revealed the heterogeneity of
the VTA and the targets of DA VTA neurons and have resulted
in revisions of our understanding of the role of the VTA in
addiction, it is still clear that the rewarding and reinforcing effects
of all drugs of abuse are at least partially related to the release of
dopamine by DA VTA neurons (Lammel et al., 2014).
Numerous studies, including those from our laboratory, have
demonstrated that ethanol increases spontaneous firing of DA
VTA neurons both in vivo (Gessa et al., 1985) and in vitro
(Brodie et al., 1990; Brodie and Appel, 1998a,b; Xiao and Ye,
2008; Xiao et al., 2009). Ethanol directly excites DAVTAneurons,
as this effect is observed in the absence of synaptic terminals
(Brodie et al., 1999a) or blockers of synaptic transmission (Brodie
et al., 1990). Ethanol-induced excitation of DA VTA neurons is
blocked by the alkaloid quinidine (Appel et al., 2003) that shows
some selectivity against delayed rectifier potassium channels,
and by phorbol esters that activate certain isoforms of protein
kinase C (Nimitvilai et al., 2013). Blocking h-current in DA
VTA neurons antagonizes ethanol excitation (Okamoto et al.,
2006), and this effect depends on activation of barium-sensitive
potassium channels (McDaid et al., 2008).
Like ethanol, toluene also increases the firing rate of DA
VTA neurons (Riegel and French, 1999) resulting in increases
in dopamine in the nucleus accumbens (Riegel et al., 2007).
Behaviorally, both toluene and ethanol act as central nervous
system depressants, although at low concentrations they can
produce hyperactivity. Both ethanol (Roberto et al., 2006) and
toluene (Beckstead et al., 2000) have been shown to enhance
GABAergic transmission either by increasing GABA release
(MacIver, 2009) or by enhancing GABAA receptor function
(Mihic, 1999; Beckstead et al., 2000). Chronic exposure to toluene
has been shown to reduce expression of the GABAA alpha1
subunit expression in the VTA (Williams et al., 2005), and
repeated exposures to ethanol also induce changes in GABA
receptor expression (Arora et al., 2013). In addition to GABA,
both toluene and ethanol potentiate serotonin 5HT3 function
(Lovinger et al., 2000; Sung et al., 2000; Lopreato et al., 2003)
and inhibit the activity of NMDA receptors (Cruz et al., 2000;
Stobbs et al., 2004). Toluene also inhibits certain subtypes of
the nicotinic acetylcholine receptor (Bale et al., 2002), while the
ethanol induced increase of NAc dopamine in vivo appears to
involve nicotinic cholinergic receptors located in the anterior
but not posterior VTA (Ericson et al., 2008). While changes in
gene expression following chronic ethanol exposure are well-
studied (Mayfield et al., 2008), less progress has been made in
the examination of those gene changes associated with toluene
treatment. In a study with C. elegans, gene expression was
differentially altered following chronic exposure to ethanol or
toluene (Davies et al., 2012). These agents also induced different
changes in locomotion with both producing decreased speed, but
different patterns of movement (Davies et al., 2012). In addition,
knock out of slo-1 and rab-3 eliminated the locomotor effects of
ethanol, but had no effects on those produced by toluene (Davies
et al., 2012).
Together, these findings suggest that there are likely some
similarities and some differences in themechanisms that underlie
the increase in firing of DA VTA neurons by ethanol and toluene.
As this has not been extensively studied, we compared the actions
of ethanol and toluene on DA VTA neuron firing under several
conditions in order to address this gap in the literature.
MATERIALS AND METHODS
Animals
Male Fischer 344 (F344; 90–150 gm) used in these studies were
obtained from Harlan Sprague-Dawley (Indianapolis, IN). All
rats were treated in strict accordance with the NIH Guide for
the Care and Use of Laboratory Animals and all experimental
methods were approved by the Animal Care Committee of the
University of Illinois at Chicago.
Preparation of Brain Slices
The technique for preparing brain slices containing the ventral
tegmental area (VTA) has been described previously (Brodie
et al., 1999b). Following rapid removal of the brain, the tissue
was blocked coronally to contain the VTA and substantia nigra.
The tissue block was mounted in the vibratome and submerged
in chilled cutting solution. Coronal sections (400µm thick)
were cut, and the slices were placed onto a mesh platform in
the recording chamber in which artificial cerebrospinal fluid
(aCSF) was flowing at 2ml/min at 35◦C. The composition of
the aCSF in these experiments was (in mM): NaCl 126, KCl 2.5,
NaH2PO4 1.24, CaCl2 2.4, MgSO4 1.3, NaHCO3 26, glucose 11.
The composition of the cutting solution in the vibratome was
(in mM): KCl 2.5, CaCl2 2.4, MgSO4 1.3, NaHCO3 26, glucose
11, and sucrose 220. Both solutions were saturated with 95%
O2/ 5% CO2 (pH = 7.4). Equilibration time of at least 1 h was
allowed after placement of tissue in the recording chamber before
electrodes were placed in the tissue.
Cell Identification
The VTA was clearly visible in the fresh tissue as a gray area
medial to the darker substantia nigra, and separated from the
nigra by white matter. Recording electrodes were placed in the
VTA under visual control. DA neurons have been shown to
have distinctive electrophysiological characteristics (Grace and
Bunney, 1984; Lacey et al., 1989). Only those neurons which were
anatomically located within the VTA and which conformed to
the criteria for DA neurons established in the literature and in
this laboratory (Lacey et al., 1989;Mueller and Brodie, 1989) were
studied. These criteria include broad action potentials (2.5ms or
greater, measured as the width of the bi- or tri-phasic waveform
at the baseline), slow spontaneous firing rate (0.5–5Hz), and
a regular interspike interval. Cells were not tested with opiate
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agonists as has been done by other groups to further characterize
and categorize VTA neurons (Margolis et al., 2006). It should
be noted that some neurons with the characteristics we used to
identify DA VTA neurons may not, in fact, be DA-containing
(Margolis et al., 2006). The fact that our recordings were generally
from lateral and posterior portions of the VTA and reports
that most neurons in this area do in fact contain dopamine
(Chieng et al., 2011), provides some confidence that neurons with
the electrophysiological characteristics noted above are, in fact,
dopamine-containing.
Drug Administration
When drugs were added to the aCSF, this was done by means
of a calibrated infusion pump from stock solutions 100–1000
times the desired final concentrations. The addition of drug
solutions to the aCSF was performed in such a way as to permit
the drug solution to mix completely with aCSF before this
mixture reached the recording chamber. Final concentrations
were calculated from aCSF flow rate, pump infusion rate,
and concentration of drug stock solution. The small volume
chamber (about 300µl) used in these studies permitted the rapid
application and washout of drug solutions. Typically drugs reach
equilibrium in the tissue after 2–3min of application. Because
of concerns about limited solubility and mixing of toluene into
the aCSF, in some experiments, toluene was added to a separate
reservoir of identical aCSF and switching between normal and
toluene-containing media were achieved using a three-way tap.
In other experiments, toluene was dissolved in DMSO (0.215ml
toluene in 10ml DMSO) and added to the superfusate in the
same manner as other agents. No difference in toluene response
was observed when both methods were compared in the same
recording (data not shown), so data using each method were
pooled.
Atropine, mecamylamine, bicuculline, CGP35348, DL-AP5,
CNQX, and ZD7288 were purchased from Tocris Biosciences
(Minneapolis, MN). Barium chloride was purchased from Fisher
Scientific (Fair Lawn, NJ). Toluene, ethanol, quinine, nicotine,
and most of the salts used to prepare the extracellular media were
purchased from Sigma (St. Louis, MO).
Extracellular Recording
Extracellular recording was chosen for these studies as this
method permits the recordings to be stable and of long duration
and allows us to assess the effects of extended exposure
(>2 h) to drugs. The limitation of only measuring spontaneous
action potential frequency (rather than membrane potential or
other electrophysiological parameters) is counterbalanced by the
advantage of being able to determine the time course of drug
actions and interactions. Extracellular recording electrodes were
made from 1.5mm diameter glass tubing with filament and were
filled with 0.9% NaCl with the addition of drugs of interest or
appropriate control vehicle. Tip resistance of the microelectrodes
ranged from 2 to 4 M. A high-gain extracellular amplifier
was used in conjunction with an IBM-PC-based data acquisition
system (ADInstruments, Inc.). Oﬄine analysis was used to
calculate, display and store the frequency of firing 1min intervals.
Additional software was used to calculate the firing rate over
5 s intervals. Firing rate was determined before and during drug
application. Firing rate was calculated over 1 min intervals prior
to administration of drugs and during the drug effect; peak drug-
induced changes in firing rate were expressed as the percentage
change from the control firing rate according to the formula
[(FRD — FRC)/FRC] × 100, where FRD is the firing rate during
the peak drug effect and FRC is the control firing rate. The
change in firing rate thus is expressed as a percentage of the
initial firing rate, which controls for small changes in firing rate
which may occur over time. This formula was used to calculate
both excitatory and inhibitory drug effects. Peak excitation was
defined as the peak increase in firing rate produced by the drug
(e.g., toluene) greater than the pre-drug baseline. Inhibition was
defined as the lowest firing rate below the pre-drug baseline.
Data Collection
For comparison of the time course of effects on firing rate,
the data were normalized and averaged. Firing rates over 1
min intervals were calculated and normalized to the 1 min
interval immediately prior to the DA administration. These
normalized data were averaged by synchronizing the data to the
DA administration period, and graphs of the averaged data were
made.
Statistical Analysis
Averaged numerical values were expressed as the mean ± the
standard error of the mean (S.E.M.). The differences among
firing rates during the long drug administration intervals in
these studies was assessed using t-tests, or with an appropriate
ANOVA followed by Tukey post-hoc comparisons (Kenakin,
1987). Statistical analyses were performed with GraphPad Prism
version 6.05 (GraphPad Software, Inc., La Jolla, CA).
RESULTS
A total of 123 VTA neurons were recorded in this study. Their
initial firing rate ranged from 0.67 to 4.27 Hz, with a mean
of 1.93 ± 0.06Hz. All neurons had regular firing rates, and
conformed to the rate and patterns of DA VTA neurons as
described in the Methods above.
Toluene Concentration-Response
As has been shown by others (Riegel and French, 2002), we
initially confirmed that toluene increases firing of VTA DA
neurons in a dose-dependent manner. Following a stable baseline
period, five concentrations of toluene were tested, beginning
with 200µM toluene and increasing the concentration in a
stepwise fashion (200, 400, 600, 800, and 1000µM), with each
concentration being applied for 10min. As shown in Figure 1,
toluene induced a concentration-dependent increase in firing
rate that was significantly different from baseline [one-way
repeated measures ANOVA, F(1.6, 11.3) = 19.77, P < 0.0005,
n = 8]. Note that in some experiments, an initial inhibition was
observed prior to the excitatory response. We have observed this
with ethanol as well (Brodie et al., 1990), and these inihibitory
responses do not appear to be concentration-dependent (see
Figure 1A) and may be induced by actions of toluene or ethanol
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FIGURE 1 | Concentration-dependent excitation of DA VTA neurons by
toluene. (A) Ratemeter graph of firing rate over time recorded from a single
VTA neuron. Vertical bars indicate firing rate over a 5 s interval; horizontal bars
indicate the duration of administration of toluene (concentration indicated
above bar). Toluene produced increases in firing (in Hz) of 200µM: 1.01;
400µM: 7.35; 600µM: 15.87; 800µM: 38.16; 1000µM: 66.33. (B) Pooled
concentration-response curve of the effect of toluene on spontaneous activity
of DA VTA neurons. Toluene was added to the superfusate and concentrations
were increased in a step-wise manner (10min per step) from 200 to 1000µM
in 200µM steps. (These same data are shown in Figure 4A below as control).
on neurons in the vicinity of the cell that is the subject of
the recording. Despite the clear concentration-dependence of
toluene-induced excitation, the individual responses were quite
variable; for example, the range of responses to 600µM toluene
was 8.7–35.2% excitation, and for 1000µM toluene, the range
was 21.1–80.6% excitation. As noted above, recordings were
made from lateral VTA neurons in the posterior portion of the
VTA; we did not observe any differences in the response to
ethanol or toluene dependent on the location of the neurons in
the slice preparation.
Quinine Blocks the Excitatory Effects of
Ethanol and Toluene
We have shown previously that ethanol-induced excitation of
DA VTA neuron firing is antagonized by the alkaloid quinidine,
that, like its stereoisomer quinine, has some selectivity for
a variety of delayed rectifier K+ channels (Snyders et al.,
1992; Yeola et al., 1996; Singh and Singh, 1999; Schönherr
et al., 2002; Appel et al., 2003), although it can block sodium
(Grant et al., 1984) and calcium (Salata and Wasserstrom,
1988) channels as well. In the present study we tested
whether quinine could antagonize ethanol- and toluene-induced
excitation. As shown in Figure 2A, ethanol (80mM) and
toluene (400µM) each produced 20–30% increase in firing of
DA VTA neurons. Quinine (100 µM) significantly reduced
excitation induced by both ethanol (paired t-test, P < 0.01)
and toluene (paired t-test, P < 0.01). This finding suggests
that there is some overlap in the mechanisms of excitation
induced by ethanol and toluene in that they might both
excite DA VTA neurons through blocking quinine-sensitive K+
currents.
Concurrent Blockade of Cholinergic and
GABAergic Receptors
Evidence in the literature suggests that toluene can interact
with both cholinergic and GABAergic systems. In order to test
whether either of these systems play a direct role in toluene-
induced excitation of DA VTA neurons, we tested and compared
the effects of toluene and ethanol in the absence or presence of
antagonists of GABA (10µMbicuculline; 10µMCGP35348) and
cholinergic (1µMmecamylamine and 5 µM atropine) receptors.
The combination of antagonists alone produced a significant
increase in baseline firing rate of 17.3 ± 4.5% (paired t-test,
t = −3.088, DF = 8, P < 0.02; n = 9; Table 1). In the toluene
experiments, two concentrations (400 and 800µM) of toluene
were tested, then the combination of antagonists was added to
the superfusate, and the same two concentrations of toluene were
retested (n = 9). In a subset of experiments (n = 4), after testing
toluene in the presence of the GABA and cholinergic antagonists,
quinine (100µM) was added to the superfusate, and the same
concentrations of toluene were tested again in the presence of the
four receptor antagonists and quinine. As shown in Figure 2B,
there was no significant change in the excitatory action of
either dose of toluene on DA VTA neurons in the mixture
of GABA and cholinergic antagonists. However, the toluene-
induced increase in firing in the presence of the antagonists
was blocked by quinine [two-way ANOVA, F(2, 6) = 14.762, P
< 0.005: Tukey post-hoc comparison of means, P < 0.05 for
significance]. In a separate group of neurons, we also tested
the effect of the antagonists and quinine on ethanol-induced
excitation. Similar to the results with toluene, the antagonist
mixture had no significant effect on the excitatory action of
either 40 or 80mM ethanol (Figure 2C). Under these conditions,
ethanol-induced excitation was also blunted when quinine was
added [two-way repeated measures ANOVA, F(2, 8) = 15.27,
P < 0.002: Tukey post-hoc comparison of means, P < 0.05 for
significance]. These results confirmed that excitation by both
ethanol and toluene are mediated by a quinine-sensitive process
and suggest that the excitation of DA VTA neurons by these
drugs cannot be mediated directly by either GABA or cholinergic
neurotransmission.
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FIGURE 2 | Reduction of ethanol- and toluene-induced excitation by
quinine (A). Mean responses to ethanol (80mM) and toluene (400µM) in the
absence (gray bars) and presence of 100µM quinine (red bars). Quinine
significantly reduced the excitation produced by toluene and ethanol,
suggesting some overlap in the mechanisms of excitation by both drugs
(*paired t-test, P < 0.01). (B) Toluene (400 or 800µM) was tested before (gray
bars) and in the presence of a cocktail (M+A+C+B) of mecamylamine (1µM),
atropine (5µM), bicuculline chloride (10µM), and CGP35348 (10µM; red
bars). The effect of toluene was not altered significantly by the addition
(Continued)
FIGURE 2 | Continued
of these antagonists (n = 9). In four of these experiments, after toluene was
tested in the antagonists, 100µM quinine (blue bars) was added to the
superfusate and toluene was retested (Quinine + M+A+C+B).
Toluene-induced excitation was significantly reduced in the presence of
quinine and the four antagonists [*two-way repeated measures ANOVA, F (2, 6)
= 14.76, P < 0.005, n = 4]. (C) Ethanol (40 or 80mM) was tested before (gray
bars) and in the presence of a cocktail of mecamylamine (1µM), atropine
(5µM), bicuculline chloride (10µM), and CGP35348 (10µM; red bars). The
effect of ethanol was not altered significantly by the addition of these
antagonists (n = 5). In addition, after ethanol was tested in the antagonists,
100µM quinine (blue bars) was added to the superfusate and ethanol was
retested. Ethanol-induced excitation was significantly reduced in the presence
of quinine and the four antagonists [*two-way RM ANOVA, F (2, 8) = 15.27,
P < 0.002: Tukey post-hoc comparison of means, P < 0.05 for significance;
n = 5].
TABLE 1 | Effects of various antagonists on firing rate.
Figure number: Change in firing Significance
antagonist (s) rate (% ± SEM)
2A: quinine −17.6%±12.0 P > 0.05
2B: MACB 17.3±4.5 P < 0.02
2C: MACB 6.2±4.0 P > 0.05
3: MACB 2.0±3.4 P > 0.05
3: MACB + ethanol 19.6±2.6 P < 0.0001
4A: glutamate antagonists −2.97±3.8 P > 0.05
4B: glutamate antagonists 7.43±3.05 P < 0.05
5B: mecamylamine −0.09±6.16 P > 0.05
5C: atropine 21.0±6.7 P > 0.05
5D: GABA antagonists 9.89±3.08 P < 0.01
6: barium 58.02±16.3 P < 0.005
MACB, mecamylamine (1µM); atropine (5µM); CGP35348 (10µM); bicuculline (10µM).
Glutamate antagonists, DL-AP5 (10µM); CNQX (10µM); MCPG (10µM).
The effect of antagonists used in these experiments on firing rate, referenced to figure
number. In some cases, different groups of cells responded differently with the same
combination of antagonists due to cell-to-cell variability.
Toluene Excitation in the Presence of
Ethanol
If toluene and ethanol act on the same quinine-sensitive
membrane protein, then applying ethanol first should decrease
the subsequent excitatory effect of toluene. We therefore tested
the effect of 800µM toluene in the absence and presence
of 120mM ethanol, as these concentrations produce roughly
equivalent effects on firing. Similar to the studies discussed above,
these studies were performed in the presence of antagonists
of cholinergic (1µM mecamylamine; 5µM atropine) and
GABAergic (10µM bicuculline; 10µM CGP35348) receptors
(Figure 3A). Toluene was tested, washed out, and then 120mM
ethanol was added to the superfusate. Ten minutes after the
addition of ethanol, toluene was added in the presence of ethanol.
The mean data shown in Figure 3B illustrate that, in the presence
of the antagonists, 800µM toluene increased firing frequency by
33.4 ± 4.1%. Following washout of toluene, addition of 120mM
ethanol increased firing by 19.6 ± 2.6% (data not shown). In the
presence of ethanol, toluene increased firing by 42.5 ± 9.3%, an
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FIGURE 3 | Ethanol does not occlude toluene-induced excitation. (A)
Ratemeter diagram illustrating the results from a single VTA neuron undergoing
the protocol used in the ethanol occlusion experiments. Vertical bars indicate
the firing rate over 5 s intervals, and horizontal bars indicate the duration of
drug administration (specific drugs indicated above these bars). After
beginning a recording, the same antagonist cocktail described in the legend to
Figure 2 was added to the superfusate. Toluene (800µM) was tested and
then washed out. Then ethanol (120mM) was added to the superfusate and,
after 10min, the same concentration of toluene was tested again. In this
recording, toluene increased the firing rate by 34.0% prior to ethanol and
39.5% in the presence of ethanol, while ethanol alone produced a 15.4%
increase in firing rate. (B) Toluene (800µM) was tested before (gray bar) and in
the presence of 120 mM ethanol (red bar). Note that a cocktail of
mecamylamine (1µM), atropine (5µM), bicuculline chloride (10µM) and
CGP35348 (10µM) is present during the whole experiment. The effect of
toluene was not altered significantly by the presence of ethanol (n = 8).
amount that was not significantly different from that observed in
the absence of ethanol (paired t-test, DF= 7, t-statistic=−0.994,
n = 8). The lack of occlusion of toluene-induced excitation by
a high ethanol concentration suggests that ethanol and toluene
may act at different sites on DA VTA neurons.
Effects of Glutamate Antagonists
As glutamate is the predominant excitatory neurotransmitter
in the VTA in vivo (Kalivas, 1993), we next tested whether
blockade of glutamate receptors would alter the excitatory
actions of toluene or ethanol. A combination of an NMDA
antagonist DL-AP5 (10µM), an AMPA receptor antagonist
CNQX (10µM), and an mGluR antagonist MCPG (10µM)
was added to the superfusate; this cocktail produced only a
small, non-significant (−2.97 ± 3.8%) change in firing rate. This
suggests that, in the acute brain slice preparation, glutamate has
only a modest role in maintaining the steady-state spontaneous
activity of DA VTA neurons. In contrast, the excitatory effect
of toluene was significantly increased in the presence of the
glutamate receptor antagonists as compared to the no-antagonist
condition [two-way ANOVA, F(1, 41) = 37.01, P < 0.01, n = 8;
Figure 4A]. The analysis also revealed a significant interaction
between toluene concentration and antagonist [two-way repeated
measures ANOVA, F(2, 41) = 4.9, P < 0.02]. In contrast to
these results, the effect of ethanol on firing was not significantly
altered by the glutamate receptor antagonists [two-way ANOVA,
F(1, 51) = 0.354, P > 0.05; Figure 4B]. To determine whether
the enhanced effect of toluene in the presence of the glutamate
receptor antagonists was dependent upon other neurotransmitter
receptors, we examined the effect of toluene in the presence of
antagonists of glutamate, GABA, and acetylcholine. As shown
in Figure 4C, 800µM toluene alone produced a 53.3 ± 10.3%
increase in firing. Consistent with the results shown in Figure 2B,
in the presence of the cholinergic and GABAergic antagonists,
800µM toluene produced a 51.9 ± 13.7% increase in excitation.
In the presence of the GABA/ACh antagonists, adding the
glutamatergic antagonists resulted in a toluene-induced increase
in excitation to 81.8 ± 21.7%. There was a significant difference
in the response to toluene in the presence of all of the
antagonists compared to the other conditions [one-way repeated
measures ANOVA, F(1.3, 11.3) = 5.50, P < 0.05; n = 10;
Tukey post-hoc comparison of means, P < 0.05 for significance],
but, again, no difference in the response to toluene in the
absence or presence of the combination of cholinergic and
GABAergic antagonists. Therefore, toluene-induced excitation
is enhanced in the presence of antagonists of the glutamate
receptor.
Antagonists of Acetylcholine and GABA
Reduce Excitation Produced by Toluene
but Not That Produced by Ethanol
Despite the lack of effect of cholinergic and GABAergic
antagonists in combination on toluene or ethanol excitation
(Figures 2B,C), we chose to examine cholinergic and GABAergic
antagonists independently as well. Our previous reports suggest
that toluene inhibits both recombinant and native nicotinic
cholinergic receptors (Bale et al., 2002, 2005). To test whether
nAChRs on the VTA are involved in the alteration of firing
rate by toluene and ethanol, we recorded responses in the
absence and presence of the selective nicotinic antagonist
mecamylamine. A typical experiment is shown in Figure 5A
and the mean responses are shown in Figure 5B. Before
mecamylamine was added, ethanol (80mM), toluene (400µM),
and nicotine (500 nM) were tested and each increased the firing
rate. Mecamylamine (1µM) had no effect on its own, but
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FIGURE 4 | Effects of ethanol and toluene in the presence of glutamate
antagonists. Toluene (A) and ethanol (B) were tested in the absence or
presence of a combination of NMDA antagonist DL-AP5 (10µM), AMPA
receptor antagonist CNQX (10µM), and mGluR antagonist MCPG (10µM).
(A) Toluene alone excited the DA VTA neurons in a concentration-dependent
manner. In the presence of glutamate antagonists, there was a significant
increase in the excitatory effects of 400–800µM toluene. (B) Ethanol
(40–120mM) produced a concentration-dependent excitation. In the presence
of glutamate antagonists, ethanol-induced excitation was not changed
significantly. (C) Toluene excitation in the presence of antagonists of
cholinergic, GABAergic, and glutamatergic receptors. The effect of 800µM
(Continued)
FIGURE 4 | Continued
toluene alone (gray bar) and in the presence of a cocktail of mecamylamine
(1µM), atropine (5µM), bicuculline chloride (10µM), and CGP35348 (10µM;
red bar) and that cocktail plus a combination of NMDA antagonist DL-AP5
(10µM), AMPA receptor antagonist CNQX (10µM), and mGluR receptor
antagonist MCPG (10µM; blue bars). There was no difference in the response
to toluene in the presence of the cholinergic and GABAergic antagonists, but
there was a significant increase in the response after addition of the glutamate
antagonists [*P < 0.05, one-way repeated measures ANOVA,
F (1.3, 11.3) = 5.50, n = 10].
it significantly blunted the increase caused by nicotine [two-
way ANOVA, F(2, 46) = 23.26, P < 0.001; n = 9] while
having no significant effect on toluene or ethanol excitation.
It should be noted that while only one of nine neurons
showed reduction of ethanol excitation by mecamylamine,
in 4 of 8 neurons tested, mecamylamine completely or
nearly completely blocked toluene excitation. Sensitivity to
mecamylamine was not dependent on initial firing rate, and
all of the neurons were located in a similar region of
the VTA.
As DA VTA neurons also have muscarinic cholinergic
receptors (Lacey et al., 1990), we determined whether blocking
muscarinic receptors with atropine would alter toluene-
induced excitation. Toluene (400 and 800µM) was tested in
the absence and presence of 5µM atropine; atropine alone
increased firing rate by ∼21% (Table 1). In the presence
of atropine, toluene excitation of firing was significantly
reduced and this was especially apparent at the higher
toluene concentration [two-way ANOVA, F(1, 3) = 20.74,
P < 0.02, n = 4; Figure 5C]. This finding suggests that
there may be cholinergic interactions with toluene-induced
excitation.
There is a large GABAergic innervation of DA VTA neurons
(Bayer and Pickel, 1991), and GABAergic neurotransmission
plays an important role in regulating the firing of VTA DAergic
neurons (Theile et al., 2008, 2011; Xiao and Ye, 2008; Steffensen
et al., 2009). We tested whether excitation induced by either
ethanol or toluene was affected by GABA antagonists. The
excitatory effects of 80mM ethanol and 400–800µM toluene
were tested before and after the addition of GABA antagonists to
the external medium. Figure 5D illustrates the effect of addition
of the GABAA antagonist bicuculline (10µM), and the GABAB
antagonist CGP35348 (10µM) on toluene and ethanol excitation.
GABAA antagonist bicuculline plus CGP35348 produced a small
but significant increase in firing rate (Table 1). Prior to adding
the GABA antagonists, ethanol excitation was 27.7 ± 3.2% and
this did not change in the presence of the GABA antagonists
(29.6 ± 5.4%). In contrast, under control conditions, toluene
excitation was 38.4 ± 7.9% and this declined to 18.8 ± 3.9%
when the recordings were carried out in the presence of GABA
antagonists [two-way ANOVA, F(1, 13) = 10.44, P < 0.01, n =
14; Figure 5D]. These results indicate that concurrent block of
GABAA and GABAB receptors can modulate toluene-induced
excitation, and illustrates another difference between toluene and
ethanol.
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FIGURE 5 | Cholinergic and GABAergic antagonists reduce toluene-induced excitation, but have no effect on excitation produced by ethanol. (A)
Ratemeter: Firing rate over 5 s intervals is represented by the height of the vertical bars; duration of drug application is shown by the horizontal bars. Ethanol (EtOH,
80mM), toluene (400µM) and nicotine (500 nM) were tested before and in the presence of mecamylamine (1µM). All three drugs produced excitation in the absence
of mecamylamine, but in the presence of mecamylamine, there was a reduction in the excitation produced by nicotine and toluene, with no diminution of the
ethanol-induced excitation. Despite the reduction in toluene-induced excitation by mecamylamine in this recording, there was no significant effect of mecamylamine
on toluene excitation in the population of responses studied overall. (B) Bars representing the mean responses to ethanol, toluene, and nicotine in the absence (gray
bars) and presence (red bars) from the pool of experiments similar to the one depicted in (A). Due to the variation in responses in the presence of mecamylamine,
individual responses in the absence (round symbols) and presence (square symbols) are shown superimposed on the bars. Mecamylamine significantly reduced the
excitation produced by nicotine but not that produced by toluene or ethanol. (C) Toluene (400 or 800µM) was tested before (gray bars) and after the addition of 5µM
atropine to the superfusion medium (red bars). In the presence of atropine, the effects of 800µM toluene were significantly reduced [two-way ANOVA, F (1, 3) = 20.74,
P < 0.02, n = 4]. (D) The effects of ethanol (80mM; gray bars) and toluene (400–800µM; red bars) were assessed before and after addition of the GABAA antagonist
bicuculline (10µM) and GABAB antagonist CGP35348 (10µM) to the superfusion medium. Ethanol-induced excitation was not significantly altered by the GABA
antagonists, but the excitation produced by toluene was significantly reduced [*P < 0.05, two-way ANOVA, F (1, 13) = 10.44, P < 0.01, n = 14].
Effect of Toluene in the Presence of
ZD7288
DA VTA neurons possess hyperpolarization-activated cyclic
nucleotide-gated current (h-current) that has been demonstrated
to be sensitive to ethanol (Brodie and Appel, 1998b; Okamoto
et al., 2006; McDaid et al., 2008). Previous studies have
demonstrated that ethanol excitation of DA VTA neurons is
reduced in the presence of the selective h-channel blocker,
ZD7288 (Okamoto et al., 2006; McDaid et al., 2008). This
reduction of ethanol excitation results from the opening
of ethanol-sensitive G protein-coupled inwardly rectifying
potassium (GIRK) channels; in the presence of the GIRK channel
blocker barium, ZD7288 no longer affects ethanol excitation
(McDaid et al., 2008). Therefore, inhibitory barium-sensitive
currents that are activated by ethanol aremodulated by h-current,
and blockade of h-current by ZD7288 reveals this inhibition
that counteracts the excitatory effect of ethanol (McDaid et al.,
2008). For comparison with these published results, we examined
the action of toluene in the presence of ZD7288. The excitatory
effect of 400 and 800µM toluene was essentially eliminated
by 20µM ZD7288 (Figure 6, gray bars, n = 10), but, unlike
our results with ethanol, the effect of ZD7288 on toluene-
induced firing was not reversed by the GIRK channel blocker
barium chloride (Figure 6, blue bars). However, toluene-induced
excitation of firing was again observed if ZD7288 was co-
administered with antagonists of GABAA (bicuculline 10µM)
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FIGURE 6 | Effect of toluene in the presence of ZD7288 and GABA
antagonists. Toluene (400 or 800µM) was tested in the presence of ZD7288
(20µM) (gray), ZD7288 plus 100µM barium (blue), or ZD7288 and a
combination of GABA antagonists [GABA-A antagonist bicuculline (10µM) and
GABA-B antagonist CGP35348 (10µM); red]. With ZD7288 in the medium,
there was an apparent blockade of the excitatory effects of toluene. This
blockade of toluene-induced excitation was not reversed by the addition of
barium to the medium. In the presence of ZD7288 and GABA antagonists,
there was a significant restoration of the toluene-induced excitation
(P < 0.001; two-way Anova, F(2, 40) = 9.24; *P < 0.05).
and GABAB (CGP35348 10µM) receptors [Figure 6, red bars;
two-way ANOVA, F(2, 40) = 9.24, P < 0.001; Tukey post-hoc
comparison of means, P < 0.05 for significance]. These data
indicate that while the h-channel blocker ZD7288 can appear to
block toluene-induced excitation, similar to its effect on ethanol-
induced excitation, this action requires functional GABAA and
GABAB receptors.
DISCUSSION
Previous studies show that toluene (Riegel and French, 2002;
Riegel et al., 2007) and ethanol (Brodie et al., 1999a) increase
the firing rate of dopaminergic neurons of the VTA. In
the present study, we compared the responses of DA VTA
neurons to ethanol and toluene under similar experimental
conditions, and in many cases the same neurons. In summary,
the results of this study show that the excitation produced
by either drug is blocked by quinine and that the actions
of both drugs are regulated, albeit differently, by ZD7288-
sensitive h-current. The lack of reduction of toluene excitation
in the presence of ethanol suggests that these drugs act on
different molecular targets. Muscarinic cholinergic receptors
and GABA receptors appear to regulate toluene, but not
ethanol, excitation. Finally, while our previously published
work demonstrated that block of h-currents allows for ethanol
inhibition of firing via opening of barium-sensitive potassium
channels (McDaid et al., 2008), we show here that blocking
h-current uncovers a toluene-induced activation of GABA-
activated channels.
Results from the various pharmacological antagonist
experiments performed in the present study (Table 2) revealed
TABLE 2 | Summary of the effects of agents tested in this study.
Toluene Ethanol
Quinine reduced reduced
MACB combination no effect no effect
Ethanol no effect N/A
Glutamate antagonists Increased no effect
MACB combination + Glu antagonists Increased no effect
Mecamylamine no effect no effect
Atropine decreased no effect
ZD7288 decreased decreased
ZD7288 + barium decreased no effect*
ZD7288 + GABA antagonists no effect not tested
MACB, mecamylamine (1 µM); atropine (5 µM); CGP35348 (10 µM); bicuculline (10 µM).
Glutamate antagonists, DL-AP5 (10 µM); CNQX (10 µM); MCPG (10 µM).
*Tested previously by our laboratory in McDaid et al. (2008).
Comparison of the effects of antagonists on ethanol and toluene excitation.
significant differences between ethanol and toluene in the
regulation of DA VTA neuronal excitability. Interestingly, the
combination of GABAA and GABAB antagonists had no effect
on ethanol-induced excitation, but significantly suppressed
excitation produced by toluene, and when applied alone,
neither GABAA nor GABAB antagonists significantly affected
toluene-induced excitation. This observation could reflect
a complex interaction between excitatory and inhibitory
actions of toluene on GABA neurotransmission. This
complexity is underscored further by the lack of effect of a
combination of GABAergic and cholinergic antagonists on
toluene-induced excitation. The results indicate that neither
cholinergic nor GABAergic processes play direct roles in
toluene-induced excitation, but may serve to modulate that
excitation.
One point that bears further examination is the lack of
effect of the combination of receptor antagonists (Figure 2,
MACB conditions), despite the significant effects of subsets of
antagonists (GABA antagonists, for example) to reduce toluene-
induced excitation. Likewise, the lack of effect of either GABA
antagonist alone despite the significant effect of the combination
is somewhat perplexing. We suggest that these observations are
gemaine to studies of ethanol as well as toluene, and illustrates
the difference between antagonism of a primary mechanism
and antagonism of a modulatory influence. Numerous studies
have suggested that ethanol excitation is mediated by cholinergic
(Larsson et al., 2002), GABAergic (Ludlow et al., 2009; Theile
et al., 2011; Guan et al., 2012), glutamatergic (Xiao et al.,
2009), or combinations of neurotransmitter systems (Engle et al.,
2015). We previously have shown that ethanol excites acutely
isolated DA VTA neurons that were enzymatically treated to
eliminate synaptic contacts (Brodie et al., 1999a), indicating
neither neurotransmitter receptor activation nor blockade is
needed to produce ethanol excitation. In concurrence with
that earlier study, the present study demonstrates that none
of the receptor antagonist combinations significantly reduced
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ethanol excitation. For both ethanol and toluene, the h-
channel blocker ZD7288 produces an apparent antagonism
of ethanol (Okamoto et al., 2006) and toluene (Figure 2B)
excitation. In the case of ethanol, this antagonism is reversed
by barium (McDaid et al., 2008) and in the case of toluene,
this antagonism is reversed by GABA blockers (Figure 6). In
both cases, ZD7288 is not blocking the excitatory mechanism,
but is revealing an inhibitory component of the response to
ethanol or toluene. The effects of these inhibitory responses are
muted or silenced by the shunting of inhibitory current by h-
channels. Quinine [and quinidine in the case of ethanol (Appel
et al., 2003)] blocked the excitation in a more direct manner;
all of the other effective antagonists blocked a modulatory
influence that affected the expression of the excitation without
directly altering the excitation itself. Unfortunately, quinine
has actions on many ion channels, including delayed rectifier
potassium channels, sodium channels, and calcium channels
thus preventing absolute identification of the toluene sensitive
component.
The information about neurotransmitter receptor roles in
modulation of toluene excitation may be relevant to associated
effects of toluene in the VTA not directly related to the excitatory
action. In addition to a GABA-related excitatory effect of toluene
(perhaps via disinhibition of GABAergic inputs onto the DAVTA
neurons), the results from the ZD7288 experiments suggest that
toluene activates GABAA channels, an effect that becomes more
significant when h-current is blocked. As h-current is activated by
negative membrane potentials, any hyperpolarizing event (such
as opening of GABAA channels) would likely increase h-current,
thereby shunting the effects of the inhibitory current. Blocking
h-current with ZD7288 thus would prevent that shunting and
reveal an inhibitory action. This hypothesis is the same as
one we previously offered to explain the action of ZD7288
on ethanol excitation (McDaid et al., 2008). In the case of
ethanol, barium restored ethanol-induced excitation of DA VTA
neurons, suggesting an ethanol-induced opening of barium-
sensitive channels, a finding consistent with previous studies
showing GIRK activation by ethanol (Lewohl et al., 1999). In the
case of toluene, adding barium with ZD7288 did not restore the
excitation, indicating a different mechanism for ZD7288 block
of toluene excitation. Note that it has been shown that ethanol
activates GIRK channels (Lewohl et al., 1999), and that toluene
inhibits GIRK channels (Del Re et al., 2006). It is unlikely that
GABAB receptors are involved, as GABAB receptors are largely
coupled to barium-sensitive GIRKs (Watts et al., 1996). In the
presence of ZD7288, blockade of GABA receptors was sufficient
to restore toluene-induced excitation, again indicating that the
degree of activation of h-current is a key determinant as to
whether toluene exerts a net excitatory or inhibitory effect on
firing. Enhancement of GABAA receptor function by toluene
has been demonstrated in hippocampal slices and Xenopus
oocytes expressing α1β1 GABAA receptors (Beckstead et al.,
2000). Additional studies will be necessary to determine whether
the toluene-sensitive GABA receptors predicted by the results
of the present study reside on DA VTA neurons, on VTA
GABAergic interneurons, or on presynaptic inputs to DA VTA
neurons.
The muscarinic antagonist atropine also significantly
decreased excitation induced by 800µM toluene, suggesting
the involvement of muscarinic cholinergic receptors. In
contrast, the nicotinic receptor antagonist mecamylamine
did not significantly reduce toluene- or ethanol-induced
excitation. Previous studies by our laboratory show that
toluene inhibits native nicotinic cholinergic receptors on
hippocampal neurons and recombinant forms including
α4β2 expressed in Xenopus oocytes (Bale et al., 2002, 2005).
Likewise, toluene inhibits muscarinic receptor-mediated calcium
release from intracellular stores in neural precursor cells (Wu
et al., 2002), and decreases acetylcholine release in striatum
(Honma and Suda, 2004). Note that all of these effects of
toluene decrease cholinergic neurotransmission, and thus
would be predicted to inhibit DA VTA neuronal firing, since
both muscarinic (Lacey et al., 1990) and nicotinic (Brodie,
1991; Pidoplichko et al., 1997) receptors excite these neurons.
This fact, coupled with the insensitivity of toluene-induced
excitation to a mixture of cholinergic and GABAergic receptor
antagonists, indicates that cholinergic processes regulate toluene-
induced excitation in an indirect way, possibly via effects on
GABAergic transmission. Again, as with GABA receptors,
determining the location of cholinergic receptors that regulate
toluene-induced excitation will require extensive additional
studies.
Somewhat surprisingly, we found that glutamate antagonists,
even when applied in the presence of GABA and cholinergic
antagonists, potentiated the excitatory effects of toluene on
firing with no significant effect on ethanol excitation. While
glutamate antagonists did not significantly change firing
rate in the toluene experiments when applied alone, it is
possible that tonic glutamate release in the slice promotes
opening of glutamate-activated ion channels, resulting in a
tonic reduction of membrane resistance. Via Ohm’s law,
blocking these receptor-generated currents would increase
overall resistance, and thus boost the excitatory action of
toluene. The lack of potentiation of ethanol excitation under
these conditions suggests that toluene and ethanol activate DA
VTA neurons through different mechanisms. These differences
may be related to the relationship between glutamate receptors
and the toluene-sensitive and ethanol-sensitive elements. For
example, if the toluene-sensitive elements are located nearer
to glutamate receptors on the neuronal membrane, there
may be a more significant effect of glutamate antagonists
on toluene-induced currents compared to ethanol-induced
currents. Alternatively, toluene may increase glutamate release,
producing a dynamic reduction in membrane resistance
concurrently with the toluene-induced excitation. Additional
studies will be needed to determine the mechanism by which
blockade of glutamate receptors potentiates toluene-induced
excitation.
Overall, the results of the studies presented here indicate
that while both toluene and ethanol excite DA VTA neurons,
the mechanisms underlying these effects are complex and likely
reflect discrete differences in their cellular sites of action.
Elucidating these diverse actions may reveal novel means by
which the response of DA VTA neurons to drugs of abuse may
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be modulated, leading to the development of more effective
pharmacotherapeutics to treat addiction.
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